TUDORZA
Total Payments
$15.5M
Transactions
1,798
Doctors
21
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $4.0M | 841 | 13 |
| 2017 | $11.5M | 957 | 8 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $15.5M | 1,780 | 100.0% |
| Food and Beverage | $366.39 | 17 | 0.0% |
| Travel and Lodging | $173.65 | 1 | 0.0% |
Payments by Type
Research
$15.5M
1,780 transactions
General
$540.04
18 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Double blind Randomized Placebo controlled Parallel group Study to Evaluate the Effect of Aclidinium Bromide on Long Term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD | AstraZeneca Pharmaceuticals LP | $15.5M | 5 |
Top Doctors Receiving Payments for TUDORZA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Tucson, AZ | $15.5M | 1,771 |
| , D.O | Family Medicine | Columbus, OH | $18,020 | 2 |
| , MD | Critical Care Medicine | Spokane, WA | $1,476 | 2 |
| , MD | Internal Medicine | Melbourne, FL | $1,000 | 1 |
| , MD | Family Medicine | Fremont, NE | $737.84 | 2 |
| , DO | Family Medicine | Nellis Afb, NV | $567.57 | 2 |
| , M.D | Pulmonary Disease | Baltimore, MD | $314.59 | 3 |
| Hew Quon | — | Los Angeles, CA | $19.90 | 1 |
| , M.D | Internal Medicine | Cleveland, OH | $18.38 | 1 |
| , MD | Internal Medicine | Phoenix, AZ | $18.38 | 1 |
| , MD | Specialist | Farragut, TN | $18.22 | 1 |
| , M.D | Family Medicine | Puyallup, WA | $17.10 | 1 |
| , MD | Internal Medicine | New York, NY | $15.56 | 1 |
| , DO | Family Medicine | Waterford, MI | $14.47 | 1 |
| , M.D | Family Medicine | Fountain Hills, AZ | $14.34 | 1 |
| , DO | Family Medicine | Neosho, MO | $14.20 | 1 |
| , MD | Internal Medicine | Paradise Valley, AZ | $14.19 | 1 |
| , M.D | Specialist | Mukwonago, WI | $12.91 | 1 |
| , MD | Family Medicine | Roanoke, VA | $12.88 | 1 |
| , D.O | Family Medicine | Mount Vernon, IN | $12.30 | 1 |
| , M.D | Allergy & Immunology | Tampa, FL | $11.47 | 1 |
| , M.D | Ophthalmology | Deland, FL | $11.15 | 1 |
Ad
Manufacturing Companies
- AstraZeneca Pharmaceuticals LP $15.5M
- Allergan Inc. $11.15
Product Information
- Type Drug
- Total Payments $15.5M
- Total Doctors 21
- Transactions 1,798
About TUDORZA
TUDORZA is a drug associated with $15.5M in payments to 21 healthcare providers, recorded across 1,798 transactions in the CMS Open Payments database. The primary manufacturer is AstraZeneca Pharmaceuticals LP.
Payment data is available from 2017 to 2018. In 2018, $4.0M was paid across 841 transactions to 13 doctors.
The most common payment nature for TUDORZA is "Unspecified" ($15.5M, 100.0% of total).
TUDORZA is associated with 1 research study, including "Double blind Randomized Placebo controlled Parallel group Study to Evaluate the Effect of Aclidinium Bromide on Long Term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD" ($15.5M).